The impact of CPAP therapy on cardiomyocytes is reflected in the form of changes in cardiac biomarkers like ANP, NT-proBNP (reduced), and highly sensitive troponin C (normal or increased) in OSA patients associated with CVD when compared to patients with OSA alone. Here, NPPA is linked to obstructive sleep apnea syndrome.